Episode 223: Oncogenic Viruses
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Episode 223: Oncogenic Viruses” inside PodZeus.
In Episode 223 of Rio Bravo Q Week, medical students Meher Poporai and Jeremy Pan dive into the world of oncogenic viruses—viruses that can cause cancer. They begin with a framework explaining three main mechanisms: direct oncogenesis (disrupting tumor suppressors like p53 and RB), chronic inflammation leading to DNA damage, and immune evasion that impairs the body’s ability to detect abnormal cells. The episode then explores key oncogenic viruses, including HPV (linked to cervical, anal, and oropharyngeal cancers), EBV (associated with Burkitt lymphoma, nasopharyngeal carcinoma, and Hodgkin lymphoma), hepatitis B and C (major causes of hepatocellular carcinoma), HTLV-1 (causing adult T-cell leukemia/lymphoma), HHV-8 (responsible for Kaposi’s sarcoma in immunocompromised patients), Merkel cell polyomavirus (linked to aggressive skin cancer), and HIV (which indirectly increases cancer risk by weakening immune surveillance). The hosts emphasize the importance of prevention through vaccination (HPV, Hep B), early screening, and antiretroviral therapy, highlighting how public health interventions like the HPV vaccine have led to near-zero infection rates in vaccinated populations. They conclude with actionable takeaways for clinical practice, including maintaining high suspicion for HPV-related cancers in young non-smokers and aggressive cancers in immunocompromised individuals. The episode underscores a powerful message: many cancers are preventable through vaccines and early detection. The hosts stress that oncogenic viruses represent a critical intersection of infectious disease and oncology, where prevention is not just possible but already transforming outcomes. They highlight the success of the HPV vaccine in Scotland, the curative potential of DAA therapy for Hep C, and the life-saving impact of ART in reducing HIV-associated cancers. The tone is optimistic and empowering, emphasizing that medicine has made remarkable strides in turning cancer prevention into a reality through targeted public health strategies.
HPV and Hep B vaccines are highly effective in preventing cancers; the HPV vaccine has led to zero cases in vaccinated populations in Scotland.
Persistent infection—not just exposure—is key to oncogenic virus-related cancer development.
Chronic inflammation from viruses like Hep C and EBV drives cancer through repeated DNA damage and mutation.
Immune suppression (e.g., from HIV) dramatically increases cancer risk by impairing tumor surveillance.
Early screening and treatment of underlying viral infections (e.g., Hep B/C, HIV) significantly reduce long-term cancer risk.
…and 3 more takeaways available in PodZeus
Introduction and Framework for Oncogenic Viruses
“If you told someone 50 years ago, we'd be vaccinating against cancer, they probably wouldn't have believed you, but it's amazing to see how far medicine has come.”
Human Papillomavirus (HPV) and Cancer Prevention
“There were zero cases of HPV in adults who received the vaccine between 12 to 13 years of age. Zero is crazy.”
Epstein-Barr Virus (EBV) and Lymphomas
EBV’s role in B-cell immortalization and its association with Burkitt lymphoma, nasopharyngeal carcinoma, and Hodgkin lymphoma is explored. The hosts note its global cancer burden (240,000 cases/year) and the importance of clinical suspicion in diagnosis.
Hepatitis B and C: Liver Cancer Pathways
“The ability to treat Hep C is just so beneficial to population health.”
Rare Oncogenic Viruses: HTLV-1, HHV-8, and Merkel Cell Polyomavirus
The episode covers HTLV-1 (adult T-cell leukemia), HHV-8 (Kaposi’s sarcoma), and Merkel cell polyomavirus (aggressive skin cancer). Emphasis is placed on clinical recognition, lack of routine screening, and the importance of biopsy and immunotherapy.
“There were zero cases of HPV in adults who received the vaccine between 12 to 13 years of age. Zero is crazy.”
“If you told someone 50 years ago, we'd be vaccinating against cancer, they probably wouldn't have believed you, but it's amazing to see how far medicine has come.”
“HIV isn't causing the mutations directly. It's mainly creating an environment where other viruses can drive cancer development more aggressively.”
Hosts
Guest
Meher Poporai
person
Jeremy Pan
person
Human Papillomavirus
other
HIV
other
Epstein-Barr Virus
other
Hepatitis C
other
Hepatitis B
other
HPV vaccine
other
Antiretroviral therapy
product
HTLV-1
other
Episode 218: Statin Therapy Fundamentals
Rio Bravo qWeek • 17m • 4/6/2026
Episode 219: Chronic Pain and Functionality in Cancer Survivors
Rio Bravo qWeek • 15m • 4/13/2026
Episode 220: Approach of Insomnia in Adults
Rio Bravo qWeek • 28m • 4/20/2026
Episode 221: Insomnia Pharmacotherapy in Adults
Rio Bravo qWeek • 19m • 4/24/2026
Episode 222: Antibiotic Resistance
Rio Bravo qWeek • 17m • 5/1/2026
Get the full intelligence
Search transcripts, export clips, track mentions, and explore all topics from “Episode 223: Oncogenic Viruses” inside PodZeus.
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime
